Todays drug discovery is more and more about technically challenging, unprecedented drug targets. These are often multi-subunit protein complexes, membrane or membrane associated proteins such as GPCRs or ion channels or simply protein constructs with a distinct physiologically relevant function. Often these targets are hard to access and to make available in the RIGHT composition.
We call these targets “high hanging fruits” and help our customers to establish the right enabling technologies for all their discovery approaches. This opens the door to subsequently successful lead discovery and clinical programs.
Based on our scientific excellence we are the experts in high hanging fruits.
Our scientific expertise warrants the design of scientifically relevant experiments that ultimately reach the right outcomes. Only the right solutions and insights help our customers avoid downstream risk and accelerate overall research timelines.
Excellence in project execution is fundamental - we deliver what we promise, we reach the milestones, meet timelines and agreed budgets. When unexpected outcomes are encountered, we communicate in a proactive and goal oriented, forward looking manner.
We are committed to our clients and their challenges. We do not just want to perform a service but deliver the right solution and solve challenges in close cooperation. We are agile in thinking and the way we act.
We act as our clients’ discovery engine to apply our enabling Discovery Solutions technology platform and expertise in an early drug discovery "target-to-qualified hits" manner . Alternatively, you can select service components from our service portfolio as your project demands.
Elucidation of even the most complex structures through the preparation of the RIGHT protein and application of high-resolution protein crystallography and/or cryo-EM.
The science and technology platform to deliver the RIGHT challenging proteins and complexes.
At the heart of everything we do is the RIGHT protein for the right experiment. It’s knowing the protein has the right functionality, right construct, right homogeneity, right post-translational modifications, right complex composition, right stability, right species, right activity and right purity as well.
At Proteros we take care about the rightful expression, analytics-driven high-quality purification, biochemical, biophysical and structural characterization as well as early developability assessment (non GxP) for your complex biologics / antigen in a “one-stop-shop” approach.
At Proteros you can pick and choose from a wealth of affinity, binding and kinetics assay principles covering enzymatic, biochemical and biophysical assays. Our portfolio covers pre-established assays and customized assay development for profiling and screening applications.
